Thyroid Associated Ophthalmopathies

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2021-08-18
Clinical Trial Update: Selenium in Mild Thyroid Eye Disease in North America [Phase 3]
A Phase 3 clinical trial investigating selenium for mild thyroid eye disease in North America has been withdrawn.